HK1215952A1 - 新穎縮肽及其用途 - Google Patents

新穎縮肽及其用途

Info

Publication number
HK1215952A1
HK1215952A1 HK16103898.9A HK16103898A HK1215952A1 HK 1215952 A1 HK1215952 A1 HK 1215952A1 HK 16103898 A HK16103898 A HK 16103898A HK 1215952 A1 HK1215952 A1 HK 1215952A1
Authority
HK
Hong Kong
Prior art keywords
novel depsipeptide
depsipeptide
novel
Prior art date
Application number
HK16103898.9A
Other languages
English (en)
Inventor
艾倫．
．皮普爾斯
達拉斯．休斯
露希．露西．林
威廉．米蘭特
安東尼．尼迪
艾咪．斯波寧
維多利亞．亞歷山德拉．斯特德曼
珍-伊芙斯．克里斯多福．齊娃
里昂斯．拉撒瑞德
邁克爾．凱尼恩．瓊斯
卡琳．蓋爾．波林奈克
金‧路易斯
撕拉瓦．愛潑斯坦
Original Assignee
Novobiotic Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novobiotic Pharmaceuticals Llc filed Critical Novobiotic Pharmaceuticals Llc
Publication of HK1215952A1 publication Critical patent/HK1215952A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK16103898.9A 2012-12-03 2016-04-06 新穎縮肽及其用途 HK1215952A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261732894P 2012-12-03 2012-12-03
PCT/US2013/072838 WO2014089053A1 (en) 2012-12-03 2013-12-03 Novel depsipeptide and uses thereof

Publications (1)

Publication Number Publication Date
HK1215952A1 true HK1215952A1 (zh) 2016-09-30

Family

ID=49880995

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16103898.9A HK1215952A1 (zh) 2012-12-03 2016-04-06 新穎縮肽及其用途
HK18112637.4A HK1253343A1 (zh) 2012-12-03 2018-10-03 新穎縮肽及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18112637.4A HK1253343A1 (zh) 2012-12-03 2018-10-03 新穎縮肽及其用途

Country Status (10)

Country Link
US (5) US9163065B2 (zh)
EP (4) EP3916004B1 (zh)
JP (4) JP6335185B2 (zh)
AR (1) AR093705A1 (zh)
AU (5) AU2013356246B2 (zh)
CA (1) CA2890933C (zh)
ES (2) ES2882063T3 (zh)
HK (2) HK1215952A1 (zh)
TW (6) TWI686407B (zh)
WO (1) WO2014089053A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013356246B2 (en) 2012-12-03 2018-03-08 Novobiotic Pharmaceuticals, Llc Novel depsipeptide and uses thereof
KR101798176B1 (ko) * 2014-12-16 2017-11-15 주식회사 엠디헬스케어 세균 유래의 나노소포체를 이용한 세균성 감염질환 원인균 동정방법
US11046730B2 (en) 2016-04-15 2021-06-29 The Regents Of The University Of California Antimicrobial compositions
US10452951B2 (en) 2016-08-26 2019-10-22 Goodrich Corporation Active visual attention models for computer vision tasks
CN107778352B (zh) * 2016-08-29 2020-10-27 清华大学 一种用于耐药革兰氏阳性菌及结核治疗的新型抗生素
KR20190093600A (ko) * 2016-12-13 2019-08-09 훼링 비.브이. 항균 펩타이드
EP3363452A1 (en) * 2017-02-17 2018-08-22 Bayer Animal Health GmbH Combinations of lysobactin and aminogylcosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals
US11897970B2 (en) 2017-03-09 2024-02-13 The University Of Liverpool Antibacterial products
US11203616B2 (en) 2017-04-04 2021-12-21 Novobiotic Pharmaceuticals, Llc Depsipeptides and uses thereof
CN108948147B (zh) * 2017-05-22 2020-11-17 清华大学 一种用于耐药革兰氏阳性菌及结核治疗的新型抗生素
US10060366B1 (en) 2017-06-02 2018-08-28 Ford Global Technologies, Llc Transient power control method for an engine that includes a compressor
WO2019035916A1 (en) 2017-08-15 2019-02-21 Northwestern University DESIGN OF PROTEIN GLYCOSYLATION SITES BY RAPID EXPRESSION AND CHARACTERIZATION OF N-GLYCOSYLTRANSFERASES
EP3713589A4 (en) 2017-11-22 2021-10-20 University of Florida Research Foundation, Incorporated APRATYRAMIDE-BASED THERAPEUTIC AGENTS AND TREATMENT METHODS
EP3752148A1 (en) 2018-02-15 2020-12-23 Novobiotic Pharmaceuticals, LLC Pharmaceutical compositions comprising teixobactin
CN109402129B (zh) * 2018-09-30 2021-09-10 中山大学 一种广州管圆线虫Acsod3基因及其在治疗或缓解广州管圆线虫病中的应用
CN109320590B (zh) * 2018-10-31 2021-03-02 清华大学 抗生素teixobactin及其类似物的合成路线
WO2023039482A1 (en) * 2021-09-08 2023-03-16 The Regents Of The University Of California Prodrugs of antibiotic teixobactin
EP4325197A1 (en) 2022-08-19 2024-02-21 ETH Zurich A sampling device and a method for collecting microorganisms from the environment by chemotaxis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU682670B2 (en) 1993-02-05 1997-10-16 Becton Dickinson & Company Syringe needle isolation device
US5607400A (en) 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
JPH09173450A (ja) 1995-12-26 1997-07-08 Nissho Corp プレフィルドシリンジ
JP3293122B2 (ja) 1996-12-13 2002-06-17 ニプロ株式会社 プレフィルドシリンジ
SE9703425D0 (sv) 1997-09-23 1997-09-23 Pharmacia & Upjohn Ab Prefilled ampooules and manufacture thereof
DE19751219A1 (de) 1997-11-19 1999-05-27 Vetter & Co Apotheker Spritze, insbesondere vorgefüllte Spritze, oder Karpule
JP4790120B2 (ja) 1998-03-13 2011-10-12 ベクトン・ディキンソン・アンド・カンパニー 医療容器の製造、充填および包装方法
JP3591636B2 (ja) 2000-04-03 2004-11-24 ニプロ株式会社 プレフィルドシリンジ
US7011957B2 (en) 2001-09-26 2006-03-14 Northeastern University Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon
JP4141156B2 (ja) 2002-03-15 2008-08-27 日本ベクトン・ディッキンソン株式会社 プランジャ後退制限機構付きプレフィルドシリンジ
EP2386326B1 (en) 2002-07-02 2013-01-09 Terumo Kabushiki Kaisha Syringe and prefilled syringe
DE10254321A1 (de) 2002-11-21 2004-06-17 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Vorgefüllte Spritze
JP2004229750A (ja) 2003-01-28 2004-08-19 Nipro Corp プレフィルドシリンジ及びそのバレルの製造方法
AR044302A1 (es) 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
US20050075611A1 (en) 2003-10-01 2005-04-07 Hetzler Kevin G. Low extractable, thermoplastic syringe and tip cap
US7988675B2 (en) 2005-12-08 2011-08-02 West Pharmaceutical Services Of Delaware, Inc. Automatic injection and retraction devices for use with pre-filled syringe cartridges
JP4682850B2 (ja) 2006-01-12 2011-05-11 ニプロ株式会社 プレフィルドシリンジ
AU2013356246B2 (en) 2012-12-03 2018-03-08 Novobiotic Pharmaceuticals, Llc Novel depsipeptide and uses thereof

Also Published As

Publication number Publication date
ES2667753T3 (es) 2018-05-14
JP2018138589A (ja) 2018-09-06
EP3301109B1 (en) 2021-05-26
EP2925772B1 (en) 2018-02-07
EP2925772A1 (en) 2015-10-07
EP4414376A2 (en) 2024-08-14
US9402878B2 (en) 2016-08-02
US11174290B2 (en) 2021-11-16
US20170121372A1 (en) 2017-05-04
TW202400211A (zh) 2024-01-01
TWI675850B (zh) 2019-11-01
EP3916004B1 (en) 2024-03-27
TW201428004A (zh) 2014-07-16
JP2021075565A (ja) 2021-05-20
JP2023030213A (ja) 2023-03-07
JP2016505547A (ja) 2016-02-25
TW202138383A (zh) 2021-10-16
US20200024310A1 (en) 2020-01-23
US20220289793A1 (en) 2022-09-15
US20150313960A1 (en) 2015-11-05
CA2890933A1 (en) 2014-06-12
US10414800B2 (en) 2019-09-17
AU2018204040A1 (en) 2018-06-21
EP3301109A1 (en) 2018-04-04
TW202012427A (zh) 2020-04-01
ES2882063T3 (es) 2021-12-01
US11851458B2 (en) 2023-12-26
AU2023202342A1 (en) 2023-05-11
TWI686407B (zh) 2020-03-01
JP6839128B2 (ja) 2021-03-03
EP3916004A1 (en) 2021-12-01
US9163065B2 (en) 2015-10-20
AU2020201751A1 (en) 2020-03-26
US20140194345A1 (en) 2014-07-10
HK1253343A1 (zh) 2019-06-14
WO2014089053A1 (en) 2014-06-12
AR093705A1 (es) 2015-06-17
CA2890933C (en) 2021-06-08
TW202244057A (zh) 2022-11-16
JP6335185B2 (ja) 2018-05-30
AU2021209264A1 (en) 2021-08-19
AU2013356246B2 (en) 2018-03-08
TW201908332A (zh) 2019-03-01
AU2013356246A1 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
IL283139A (en) Proline-locked clamped peptides and their uses
HK1253343A1 (zh) 新穎縮肽及其用途
EP2870170A4 (en) NOVEL PEPTIDES AND THEIR USE
HK1199023A1 (zh) 取代的苯並噻吩基-吡咯並三嗪及其用途
HK1200822A1 (zh) 取代的聯吡啶胺及其用途
HK1203493A1 (zh) 取代的氮雜雙環及其用途
HK1210949A1 (zh) 組合及其用途
SG11201500111VA (en) Peptides and uses thereof
SG10201701828WA (en) Peptides and their uses
PL2855506T3 (pl) Peptydy i ich zastosowanie
HK1203198A1 (zh) 取代的苯基咪唑並吡唑及其用途
EP2825548A4 (en) MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF
EP2889307A4 (en) ALPHA-CONOTOXIN PEPTIDE AND MEDICAL COMPOSITION AND THEIR OBJECTIVE
GB201217560D0 (en) Novel cyclic depsipeptide compounds and their uses
HK1210809A1 (zh) β己糖基轉移酶及其用法
HK1211042A1 (zh) 炎症促發多肽及其用途
IL237400A0 (en) Rhizobacteria and its uses
ZA201504462B (en) TGFß-DERIVED POLYPEPTIDES AND USES THEREOF
EP2918600A4 (en) NEW PEPTIDE AND ITS USE
EP2873676A4 (en) PEPTIDE WITH LOW MOLECULAR WEIGHT AND USE THEREOF
GB201214769D0 (en) Methodsa and peptides